The Patent Finder

Modified-Release Preparations Containing Oxcarbazepine and Derivatives Thereof

Supernus Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 10 of these applications claim priority to application 60/794,837, filed Apr 26, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 7,722,898Modified-Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · High confidence
Supernus Pharmaceuticals, Inc.In force
High confidence
US 8,821,930Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,119,791Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,119,792Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,351,975Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,370,525Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,855,278Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 10,220,042Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 11,166,960Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 11,896,599Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
2 more patents in this group · Pro
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12, including 10 expiring within the 18 months from Nov 18, 2026.
Upgrade to Pro
10 of these are in force and held by Supernus Pharmaceuticals, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited